Br J Haematol 2021 Jun 10
Pembrolizumab combined with carfilzomib and low-dose dexamethasone for relapsed or refractory multiple myeloma: Cohort 2 of the phase I KEYNOTE-023 study.
Related Questions
Patient with stable disease on maintenance therapy with lenalidomide and dexamethasone
New answer by Medical Oncologist at Medical University of South Carolina (May 5, 2023)
In clinical trials, the development of a second malignancy (SM) has been considered as an indication to discontinue treatment. [Having seen people die from lenalidomide-relate...